Abstract 1606P
Background
Sarcopenia refers to the loss of muscle mass and strength that occurs with aging and due to some medical conditions like cancer. Depression and inability to eat without assistance are common effects documented in cancer patients with sarcopenia. As a result, the goal of this study was to look into the relationship between sarcopenia, depression, and modes of feeding.
Methods
During the period beginning in January 2023 and ending in April 2023, cancer patients participated in a retrospective study. There has been a total of 150 participants enrolled in the trial, all of whom have been diagnosed with cancer. These people were enrolled in Mayo Hospital's Palliative Care Cancer Department in order to receive treatment. The Patient Health Questionnaire (PHQ-9) was used to determine the presence of depressive symptoms. The SARC-F was utilized to assess sarcopenia across all five dimensions. A self-report measure was utilized to assess modes of feeding [options include: 1) unable to eat without assistance 2) (self-fed with some difficulty, and 3) self-fed without any problem]. Sarcopenia, major depressive disorder, and feeding modes were studied using correlation analysis.
Results
We have observed a significant and negative association between modes of feeding and depression (r=-0.459, p<0.01), SARC1=Strength (r = -0.326, p<0.01), SARC2=Assistance in walking (r = -0.196, p<0.05), and SARC3=Rise from a chair (r = -0.238, p<0.01). These findings show that cancer patients are unable to eat without assistance when they suffer from sarcopenia which ultimately leads to more depressive symptoms.
Conclusions
Sarcopenia has a negative impact on the quality of life of patients, leading to depression and dependence on daily activities like self-eating which further complicates management.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1857P - Psychological distress in Georgian cancer patients undergoing chemotherapy: Before and after the COVID-19 pandemic
Presenter: Mariam Abuladze
Session: Poster session 05
1858P - Discrepancies between psychological stress and emotional care in cancer patients revealed in a social listening analysis
Presenter: Dalyong Kim
Session: Poster session 05
1859P - Digital goal management training as treatment for cognitive impairment in cervical cancer survivors: A feasibility study
Presenter: Elisabeth Areklett
Session: Poster session 05
1860P - Objective and subjective neurocognitive functioning (NCF) in advanced cancer survivors treated with immune checkpoint blockade (ICB)
Presenter: Nathalie Vanlaer
Session: Poster session 05
1861P - A randomized controlled trial on the efficacy and safety of the Untire app for moderate-to-severe cancer-related fatigue in German patients
Presenter: Simon Spahrkäs
Session: Poster session 05
1862P - Measuring the prevalence of fatigue in children with cancer: Evidence from Egypt
Presenter: Nourhan Abdalkader
Session: Poster session 05
1863P - Compassion fatigue among the staff involved in medical carcinology services
Presenter: Nouha Abidi
Session: Poster session 05
1864P - To what extent do nulliparous, female adolescents and young adults diagnosed with cancer have children after cancer treatment?
Presenter: Line Bentsen
Session: Poster session 05
1865P - Women with elderly early-stage breast cancer with type A personality may have decreased self-esteem after chemotherapy: A pilot study (POSEIDON Study)
Presenter: Ozgur Tanriverdi
Session: Poster session 05
1866P - Unmasking the extent of hidden sexual distress in young breast cancer survivors
Presenter: Zeineb Naimi
Session: Poster session 05